# European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

> **NCT02852928** · — · RECRUITING · sponsor: **Matthias Griese** · enrollment: 1000 (estimated)

## Conditions studied

- Lung Diseases, Interstitial
- Pulmonary Alveolar Proteinosis
- Pulmonary Eosinophilia
- Pulmonary Fibrosis
- Respiratory Distress Syndrome, Newborn
- Child

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02852928
- **Lead sponsor:** Matthias Griese
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2013-12
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02852928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02852928, "European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02852928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*